Medicine capable of being used for treating virus hepatitis and preparation method thereof

Abstract

The invention discloses a medicine which can be used for treating viral hepatitis and a preparation method thereof. Mabao, natural bezoar, bear bile, white sandalwood, red sandalwood, agarwood, musk, iron powder, silver ash, copper ash, golden stone, Tianzhu yellow, turquoise, red coral, pearl, lapis lazuli, silver vermilion, fire nitrate, Crab, Potweed, Corydalis saibei, slag taming paste, corydalis, emblica, saffron, grass safflower, pomegranate seeds, cloves, black ice flakes, grass fruit, Indian water spinach, Kawasaki, wave melon seeds, mango Composition of seed, Zhixie Muzi, longan longan, coriander, kudzu root, cassia, myrrh, Gentiana diffusa, Meconopsis, Honglian, water cypress branch, aristolochia, gardenia and sugar; the drug It is stable in quality, safe in use, convenient to take, quick in curative effect, high in cure rate, low in recurrence rate, and has the functions of clearing away heat and promoting dampness, soothing the liver and regulating the spleen, removing blood stasis and dispelling stagnation.

Description

technical field [0001] The invention relates to the technical field of biopharmaceuticals, in particular to a medicine for treating viral hepatitis and a preparation method thereof. Background technique [0002] Viral hepatitis is an infectious disease mainly caused by liver lesions caused by a variety of hepatitis viruses. Clinically, the main manifestations are loss of appetite, nausea, upper abdominal discomfort, pain in the liver area, and fatigue. Some patients may have jaundice, fever and hepatomegaly with liver function damage. Some patients can become chronic, and even develop into liver cirrhosis, and a few can develop into liver cancer. [0003] The etiological classification of viral hepatitis has been recognized as five types of hepatitis viruses: A, B, C, D, and E, which are respectively written as HAV, HBV, HCV, HDV, and HEV. Except that hepatitis B virus is a DNA virus, The rest are RNA viruses. Hepatitis B has been reported, but the isolation of the patho...

AI Technical Summary

Problems solved by technology

③ HBcAg unit and anti-HBc: HBcAg unit positive indicates that there is a direct reaction of intact HBV particles, and HBV active replication is rarely used in clinical practice due to the complexity of the detection method

[0033] (3) Hepatitis C Because the amount of antigen in the blood is too small to be detected, it can only detect the antibody Anti-HCV is a marker of HCV infection, not a protective antibody

[0036] (6) Hepatitis G RT-PCR technology can detect Hg V RNA, which is an effective method for early diagnosis and monitoring of viremia, anti-Hg V Ig M and Ig g The unit antibody is not yet mature, and has the characteristics of low detection rate and inconsistent with RT-PCR results.

[0038] It is the main index for diagnosing various types of viral hepatitis, and it is also the definite evidence for diagnosing early liver cirrhosis, but it is not yet popular and not the first choice because of invasive examination